药物对比
Galcanezumab vs Diflunisal
Galcanezumab 是通过阻断CGRP用于偏头痛预防的单克隆抗体，而 Diflunisal 是一种带有黑框警告、用于疼痛和炎症的NSAID。选择取决于具体的医疗需求，应由医疗专业人员决定。
此页面暂无可用的对比维度。
临床背景
Individuals with chronic migraines may compare Galcanezumab, a CGRP inhibitor, to Diflunisal, an NSAID, for pain management options.
结论
Both Galcanezumab and Diflunisal are effective in their respective roles for pain and migraine management but should be used only as prescribed by a healthcare professional.
全部药物对比